| Serial Number | 87200486 |
| Word Mark | CULLINAN |
| Filing Date | Wednesday, October 12, 2016 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, June 13, 2018 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of technology in the field of oncology; Research and development of vaccines and medicines; Research in the field of oncology; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Conducting clinical trials for others; Conducting clinical trials for others in the field of oncology; Conducting scientific research in the field of oncology at animal sanctuary facilities; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Genetic testing for scientific research purposes; Laboratory research in the field of oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of oncology; Medical and scientific research information in the field of oncology; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing a website featuring educational information in the field of clinical research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Providing medical testing services and information in the field of cancer research and disease classification; Providing scientific research information in the field of oncology; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research; Scientific research and development; Scientific research consulting in the field of oncology; Scientific research for medical purposes in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology; Scientific study and research in the field(s) of oncology; Technical research in the field of pharmaceutical studies; Technology consultation and research in the field of oncology |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, October 17, 2016 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CULLINAN ONCOLOGY, LLC |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | CAMBRIDGE, MA 02142 |
| Party Name | Cullinan Pharmaceuticals, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Wednesday, August 1, 2018 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, June 13, 2018 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, June 13, 2018 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, November 3, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 3, 2017 | NON-FINAL ACTION E-MAILED |
| Friday, November 3, 2017 | NON-FINAL ACTION WRITTEN |
| Thursday, October 12, 2017 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Tuesday, September 19, 2017 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, August 31, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, August 31, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 31, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 31, 2017 | ASSIGNED TO LIE |
| Wednesday, August 16, 2017 | NOTICE OF REVIVAL - E-MAILED |
| Tuesday, August 15, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 15, 2017 | PETITION TO REVIVE-GRANTED |
| Tuesday, August 15, 2017 | TEAS PETITION TO REVIVE RECEIVED |
| Wednesday, January 18, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 18, 2017 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 18, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 18, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 18, 2017 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 18, 2017 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 17, 2017 | ASSIGNED TO EXAMINER |
| Monday, October 17, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, October 15, 2016 | NEW APPLICATION ENTERED IN TRAM |